Modulation of S6 fibrillation by unfolding rates and gatekeeper residues.

We present a protein engineering analysis of the fibrillation of a protein from a thermophilic organism, the 101 residue S6 from Thermus thermophilus. When agitated, S6 fibrillates at pH 2.0 in 0.4 M NaCl. Under these solvent conditions, S6 has native-like secondary structure and also unfolds and refolds cooperatively. However, its tertiary structure appears to be more plastic than at neutral pH, and some regions of the protein may be partially unstructured. At 42 degrees C, there is a lag phase of several days after which fibrillation takes place over several hours. Data from the fibrillation behaviour of a comprehensive series of single and double mutants of S6 suggests that several factors control the onset of fibrillation. Firstly, there appears to be a contiguous region of "gatekeeper" residues that inhibit fibrillation, since their truncation significantly reduces the duration of the lag phase. This region overlaps extensively with the partially unstructured region of the protein, suggesting that residues with enhanced flexibility and solvent-accessibility are important for the initiation of fibrillation. Secondly, longer lag phases correlate with faster rates of unfolding. We interpret this to mean that kinetic stability also controls fibrillation but in the sense that the quasi-native state, rather than the denatured state, is the species that participates in nucleation. This implies that fibrillation can also occur from a quasi-native state as opposed to an ensemble of highly fluctuating structures, and highlights the delicate balance between flexibility and structure required to form organized assemblies of polypeptide chains.

[1]  L Serrano,et al.  Similarities between the spectrin SH3 domain denatured state and its folding transition state. , 2000, Journal of molecular biology.

[2]  W. Klunk,et al.  Quantifying Amyloid β-Peptide (Aβ) Aggregation Using the Congo Red-Aβ (CR–Aβ) Spectrophotometric Assay , 1999 .

[3]  J. Kelly,et al.  Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. , 1997, Biochemistry.

[4]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[5]  I. Ekiel,et al.  Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. , 1998, Biochemistry.

[6]  J Q Trojanowski,et al.  A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.

[7]  K. Hasegawa,et al.  Amyloid Fibril Formation in the Context of Full-length Protein , 2003, Journal of Biological Chemistry.

[8]  D. Otzen,et al.  Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[10]  V. Uversky,et al.  Elucidation of the Molecular Mechanism during the Early Events in Immunoglobulin Light Chain Amyloid Fibrillation , 2002, The Journal of Biological Chemistry.

[11]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[12]  Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. , 1999 .

[13]  P. A. Evans,et al.  Kinetics of interaction of partially folded proteins with a hydrophobic dye: Evidence that molten globule character is maximal in early folding intermediates , 1995, Protein science : a publication of the Protein Society.

[14]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[15]  R. Seckler,et al.  Formation of Fibrous Aggregates from a Non-native Intermediate: The Isolated P22 Tailspike β-Helix Domain* , 1999, The Journal of Biological Chemistry.

[16]  L. Serpell,et al.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.

[17]  K. Namba,et al.  The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus. , 2000, Biochemistry.

[18]  W. Klunk,et al.  Quantifying amyloid by congo red spectral shift assay. , 1999, Methods in enzymology.

[19]  R. Wetzel,et al.  Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. , 1996, Journal of molecular biology.

[20]  Daniel E. Otzen,et al.  Conformational plasticity in folding of the split β-α-β protein S6: evidence for burst-phase disruption of the native state , 2002 .

[21]  J. Kelly,et al.  Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[23]  A. Rich,et al.  Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Liljas,et al.  Crystal structure of the ribosomal protein S6 from Thermus thermophilus. , 1994, The EMBO journal.

[25]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[26]  Christopher M. Dobson,et al.  Amyloid fibrils from muscle myoglobin , 2001, Nature.

[27]  Ehud Gazit,et al.  Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.

[28]  M. Citron,et al.  alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.

[29]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[30]  Kazufumi Takano,et al.  The structure, stability, and folding process of amyloidogenic mutant human lysozyme. , 1996 .

[31]  L. Serpell,et al.  The molecular basis of amyloidosis , 1997, Cellular and Molecular Life Sciences CMLS.

[32]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  V. Uversky,et al.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.

[34]  M. Proctor,et al.  Structural changes in the transition state of protein folding: alternative interpretations of curved chevron plots. , 1999, Biochemistry.

[35]  Christopher M. Dobson,et al.  Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.

[36]  O. Ptitsyn,et al.  Molten globule and protein folding. , 1995, Advances in protein chemistry.

[37]  H. Levine Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.

[38]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[39]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[40]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. M. Jones,et al.  pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. , 2003, Journal of molecular biology.

[42]  A. Fersht,et al.  Following co-operative formation of secondary and tertiary structure in a single protein module. , 1997, Journal of molecular biology.

[43]  Roger D Kamm,et al.  Effects of systematic variation of amino acid sequence on the mechanical properties of a self-assembling, oligopeptide biomaterial , 2002, Journal of biomaterials science. Polymer edition.

[44]  Andreas Hoenger,et al.  De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Mandelkow,et al.  Structure, Stability, and Aggregation of Paired Helical Filaments from Tau Protein and FTDP-17 Mutants Probed by Tryptophan Scanning Mutagenesis* , 2002, The Journal of Biological Chemistry.

[46]  H. Vinters,et al.  Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .

[47]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[48]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C M Dobson,et al.  Mutational analysis of the propensity for amyloid formation by a globular protein , 2000, The EMBO journal.

[50]  C. Tanford Protein denaturation. , 1968, Advances in protein chemistry.

[51]  R. Norton,et al.  The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C). , 2001, Biochimica et biophysica acta.

[52]  P. Klemm,et al.  Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae , 1987, Molecular and General Genetics MGG.

[53]  D. Otzen,et al.  Salt-induced detour through compact regions of the protein folding landscape. , 1999, Proceedings of the National Academy of Sciences of the United States of America.